Insider Transactions in Q1 2023 at Kronos Bio, Inc. (KRON)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 24
2023
|
Yasir B. Al Wakeel Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
9,026
-2.47%
|
$9,026
$1.74 P/Share
|
|
Feb 24
2023
|
Jorge Di Martino Chief Medical Officer & VP |
SELL
Open market or private sale
|
Direct |
10,153
-2.78%
|
$10,153
$1.74 P/Share
|
|
Feb 24
2023
|
Christopher Dinsmore Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
6,291
-2.16%
|
$6,291
$1.74 P/Share
|
|
Feb 15
2023
|
Jorge Di Martino Chief Medical Officer & VP |
BUY
Grant, award, or other acquisition
|
Direct |
137,008
+27.26%
|
-
|
|
Feb 15
2023
|
Barbara Kosacz COO & General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
138,911
+12.88%
|
-
|
|
Feb 15
2023
|
Christopher Dinsmore Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
119,882
+29.16%
|
-
|
|
Feb 15
2023
|
Yasir B. Al Wakeel Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
138,911
+27.58%
|
-
|